Financial Performance Highlights

Standalone Performance (FY 2025-26 vs FY 2024-25):

  • Revenue from Operations: ₹427.53 crores (up 8.93% from ₹392.49 crores)
  • EBITDA: ₹80.22 crores with 18.76% margin (up from ₹66.01 crores)
  • Profit After Tax: ₹39.72 crores (up 13.45% from ₹35.02 crores)
  • Net Cash Position: ₹134.99 crores

Consolidated Performance:

  • Revenue from Operations: ₹467.34 crores (up 6.58% from ₹438.49 crores)
  • Profit After Tax: ₹34.58 crores (up 29.41% from ₹26.72 crores)
  • Total Assets: ₹54,908.26 lakhs

Business Operations and Developments

The company maintains four manufacturing facilities at Bharuch, Pune, Nashik, and Vadodara with over 4,500 products across laboratory glassware, instruments, pharmaceutical packaging, and process systems. Key achievements include receiving the TPM Significant Award for Bharuch plant, Silver Award at Indian Manufacturing Excellence Award, and recognition among India's Top 10 Lab Equipment Manufacturers.

AGM and Corporate Governance

The 35th AGM will be held virtually on September 25, 2026, seeking approval for financial statements, director re-appointments (including Mr. Vinayak Patankar as Whole-time Director & CEO), and auditor appointments. Remote e-voting opens September 22 through NSDL platform. The board comprises 6 directors (1 Executive, 5 Non-Executive including 3 Independent Directors) with all statutory committees functional.

Financial Position and Ratios

The company maintained strong financial ratios:

  • Debt-Equity Ratio: 0.00 (improved from 0.01)
  • Return on Equity: 9.01% (up from 8.72%)
  • Net Profit Ratio: 9.29% (up from 8.92%)
  • Current Ratio: 4.68 (improved from 4.45)

Related Party Transactions and Subsidiary Performance

Significant transactions with Borosil Limited totaling ₹581.26 crores in sales. Investment in subsidiary Goel Scientific Glass Works Limited (99.37% holding) which reported revenue of ₹44.97 crores and loss of ₹4.69 crores for FY 2025-26.

Dividend and Capital Structure

No dividend recommended for FY 2025-26 to conserve resources for future growth. Paid-up equity share capital increased to ₹8.89 crores from allotment of 13,747 equity shares upon exercise of stock options under SP-ESOP 2023.

Auditor Reports and Compliance

Statutory Auditors Chaturvedi & Shah LLP and Secretarial Auditors Amogh Diwan & Associates issued unqualified reports confirming compliance with accounting standards and regulatory requirements. The company confirms compliance with all applicable laws including Companies Act, 2013 and SEBI Listing Regulations.